BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Peter Willeit, Philipp Skroblin, Stefan Kiechl, Carlos Fernández-Hernando, Manuel Mayr. Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease?European Heart Journal 2016; 37(43): 3260 doi: 10.1093/eurheartj/ehw146
2
Rocío Gallego-Durán, Manuel Romero-Gómez. Epigenetic mechanisms in non-alcoholic fatty liver disease: An emerging fieldWorld Journal of Hepatology 2015; 7(24): 2497-2502 doi: 10.4254/wjh.v7.i24.2497
3
Aida Zarfeshani, Sherry Ngo, Allan Sheppard. MicroRNA Expression Relating to Dietary-Induced Liver Steatosis and NASHJournal of Clinical Medicine 2015; 4(11): 1938 doi: 10.3390/jcm4111938
4
Xiao Lin Liu, Hai Xia Cao, Jian Gao Fan. MicroRNAs as biomarkers and regulators of nonalcoholic fatty liver diseaseJournal of Digestive Diseases 2016; 17(11): 708 doi: 10.1111/1751-2980.12408
5
Changzhou Cai, Yiming Lin, Chaohui Yu. Circulating miRNAs as Novel Diagnostic Biomarkers in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisCanadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/2096161
6
Mireia López-Riera, Isabel Conde, Guillermo Quintas, Laia Pedrola, Ángela Zaragoza, Judith Perez-Rojas, Mario Salcedo, Salvador Benlloch, José V. Castell, Ramiro Jover. Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkersScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-28854-4
7
Yan Guo, Yanhua Xiong, Quanghu Sheng, Shilin Zhao, Julia Wattacheril, Charles Robb Flynn. A micro-RNA expression signature for human NAFLD progressionJournal of Gastroenterology 2016; 51(10): 1022 doi: 10.1007/s00535-016-1178-0
8
S. Georgiou, V. Pantazopoulou, Ema Anastasiadou. The Human Gut-Liver-Axis in Health and Disease2019; : 207 doi: 10.1007/978-3-319-98890-0_13
9
Lauren A. Newman, Michael J. Sorich, Andrew Rowland. Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver DiseaseJournal of Clinical Medicine 2020; 9(7): 2032 doi: 10.3390/jcm9072032
10
Fung Zhao. Obesity, Fatty Liver and Liver CancerAdvances in Experimental Medicine and Biology 2018; 1061: 79 doi: 10.1007/978-981-10-8684-7_7
11
Elena Piccinin, Maria Arconzo, Giusi Graziano, Michele Vacca, Claudia Peres, Elena Bellafante, Gaetano Villani, Antonio Moschetta. Hepatic MicroRNA Expression by PGC-1α and PGC-1β in the MouseInternational Journal of Molecular Sciences 2019; 20(22): 5735 doi: 10.3390/ijms20225735
12
Shengliang Xin, Qiao Zhan, Xiaofan Chen, Jinghang Xu, Yanyan Yu. Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: a systematic review and meta-analysisBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01334-8
13
Kimberley D. Bruce, Felino R. Cagampang. Parental Obesity: Intergenerational Programming and Consequences2016; : 255 doi: 10.1007/978-1-4939-6386-7_12
14
Hung-Yu Lin, Ya-Ling Yang, Pei-Wen Wang, Feng-Sheng Wang, Ying-Hsien Huang. The Emerging Role of MicroRNAs in NAFLD: Highlight of MicroRNA-29a in Modulating Oxidative Stress, Inflammation, and BeyondCells 2020; 9(4): 1041 doi: 10.3390/cells9041041
15
Jia-Hung Ye, Jung Chao, Ming-Ling Chang, Wen-Huang Peng, Hao-Yuan Cheng, Jiunn-Wang Liao, Li-Heng Pao. Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid β-oxidationScientific Reports 2016; 6(1) doi: 10.1038/srep33102
16
Andrey Turchinovich, Ancha Baranova, Oksana Drapkina, Alexander Tonevitsky. Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated DisordersFrontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.01256
17
Monika Gjorgjieva, Cyril Sobolewski, Dobrochna Dolicka, Marta Correia de Sousa, Michelangelo Foti. miRNAs and NAFLD: from pathophysiology to therapyGut 2019; 68(11): 2065 doi: 10.1136/gutjnl-2018-318146
18
Prasanna K. Santhekadur, Divya P. Kumar. RISC assembly and post-transcriptional gene regulation in Hepatocellular CarcinomaGenes & Diseases 2020; 7(2): 199 doi: 10.1016/j.gendis.2019.09.009
19
Johanna K. DiStefano, Glenn S. Gerhard. Circulating microRNAs in nonalcoholic fatty liver diseaseExpert Review of Gastroenterology & Hepatology 2016; 10(2): 161 doi: 10.1586/17474124.2016.1125290
20
Yuanjie Yu, Jie Zhu, Juan Liu, Mengjun Huang, Jin‐Xiang Wan. Identification of 8‐miRNAs as biomarkers for nonalcoholic fatty liver diseaseJournal of Cellular Physiology 2019; 234(10): 17361 doi: 10.1002/jcp.28356
21
Jie Liu, Yue Xiao, Xikun Wu, Lichun Jiang, Shurong Yang, Zhiming Ding, Zhuo Fang, Haiqing Hua, Mark Stephen Kirby, Jianyong Shou. A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitisBMC Genomics 2018; 19(1) doi: 10.1186/s12864-018-4575-3
22
Víctor Micó, Laura Díez-Ricote, Lidia Daimiel. Nutrigenetics and Nutrimiromics of the Circadian System: The Time for Human HealthInternational Journal of Molecular Sciences 2016; 17(3): 299 doi: 10.3390/ijms17030299
23
Mingzhe Zhu, Qianlei Wang, Wenjun Zhou, Tao Liu, Lili Yang, Peiyong Zheng, Li Zhang, Guang Ji. Integrated analysis of hepatic mRNA and miRNA profiles identified molecular networks and potential biomarkers of NAFLDScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-25743-8
24
Siti Aishah Sulaiman, Nor I. A. Muhsin, Rahman Jamal. Regulatory Non-coding RNAs Network in Non-alcoholic Fatty Liver DiseaseFrontiers in Physiology 2019; 10 doi: 10.3389/fphys.2019.00279
25
Dan-dan Wang, Xiu Chen, Dan-dan Yu, Su-jin Yang, Hong-Yu Shen, huan-huan Sha, Shan-liang Zhong, Jian-hua Zhao, Jin-hai Tang. miR-197: A novel biomarker for cancersGene 2016; 591(2): 313 doi: 10.1016/j.gene.2016.06.035
26
Caroline M. Junker Mentzel, Ferhat Alkan, Helle Keinicke, Mette J. Jacobsen, Jan Gorodkin, Merete Fredholm, Susanna Cirera, Yun Zheng. Joint Profiling of miRNAs and mRNAs Reveals miRNA Mediated Gene Regulation in the Göttingen Minipig Obesity ModelPLOS ONE 2016; 11(11): e0167285 doi: 10.1371/journal.pone.0167285
27
Chao Sun, Jian-Gao Fan, Liang Qiao. Potential Epigenetic Mechanism in Non-Alcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2015; 16(12): 5161 doi: 10.3390/ijms16035161
28
Kishor Pant, Senthil K. Venugopal. Circulating microRNAs: Possible role as non-invasive diagnostic biomarkers in liver diseaseClinics and Research in Hepatology and Gastroenterology 2017; 41(4): 370 doi: 10.1016/j.clinre.2016.11.001
29
Arash Veshkini, Abdollah Mohammadi-Sangcheshmeh, Ali A. Alamouti, Fatemeh Kouhkan, Abdolreza Salehi. Maternal supplementation with fish oil modulates inflammation-related MicroRNAs and genes in suckling lambsTropical Animal Health and Production 2020; 52(4): 1561 doi: 10.1007/s11250-019-02157-w
30
Emma Raitoharju, Ilkka Seppälä, Leo-Pekka Lyytikäinen, Jorma Viikari, Mika Ala-Korpela, Pasi Soininen, Antti J. Kangas, Melanie Waldenberger, Norman Klopp, Thomas Illig, Jaana Leiviskä, Britt-Marie Loo, Niku Oksala, Mika Kähönen, Nina Hutri-Kähönen, Reijo Laaksonen, Olli Raitakari, Terho Lehtimäki. Blood hsa-miR-122-5p and hsa-miR-885-5p levels associate with fatty liver and related lipoprotein metabolism—The Young Finns StudyScientific Reports 2016; 6(1) doi: 10.1038/srep38262
31
Cheng Zhang, Ping Wang, Yongqiang Li, Changxin Huang, Wei Ni, Yidan Chen, Junping Shi, Gongying Chen, Xiangrong Hu, Meng Ye, Shiwei Duan, Kaifeng Wang. Role of MicroRNAs in the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver DiseaseThe Anatomical Record 2019; 302(2): 193 doi: 10.1002/ar.23954
32
Chi-Yu Lai, Chiu-Ya Lin, Chia-Chun Hsu, Kun-Yun Yeh, Guor Mour Her. Liver-directed microRNA-7a depletion induces nonalcoholic fatty liver disease by stabilizing YY1-mediated lipogenic pathways in zebrafishBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2018; 1863(8): 844 doi: 10.1016/j.bbalip.2018.04.009
33
Marta Afonso, Pedro Rodrigues, André Simão, Rui Castro. Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular CarcinomaJournal of Clinical Medicine 2016; 5(3): 30 doi: 10.3390/jcm5030030
34
Susanne Schuster, Daniel Cabrera, Marco Arrese, Ariel E. Feldstein. Triggering and resolution of inflammation in NASHNature Reviews Gastroenterology & Hepatology 2018; 15(6): 349 doi: 10.1038/s41575-018-0009-6
35
Amir Zarrinpar, Shakti Gupta, Mano R Maurya, Shankar Subramaniam, Rohit Loomba. Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective studyGut 2016; 65(9): 1546 doi: 10.1136/gutjnl-2015-309456
36
Zhen He, Cheng Hu, Weiping Jia. miRNAs in non-alcoholic fatty liver diseaseFrontiers of Medicine 2016; 10(4): 389 doi: 10.1007/s11684-016-0468-5
37
Chang-Hai Liu, Javier Ampuero, Antonio Gil-Gómez, Rocío Montero-Vallejo, Ángela Rojas, Rocío Muñoz-Hernández, Rocío Gallego-Durán, Manuel Romero-Gómez. miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysisJournal of Hepatology 2018; 69(6): 1335 doi: 10.1016/j.jhep.2018.08.008
38
Paola Dongiovanni, Marica Meroni, Miriam Longo, Silvia Fargion, Anna Fracanzani. miRNA Signature in NAFLD: A Turning Point for a Non-Invasive DiagnosisInternational Journal of Molecular Sciences 2018; 19(12): 3966 doi: 10.3390/ijms19123966
39
Jooho Lee, Yuri Kim, Simonetta Friso, Sang-Woon Choi. Epigenetics in non-alcoholic fatty liver diseaseMolecular Aspects of Medicine 2017; 54: 78 doi: 10.1016/j.mam.2016.11.008
40
Jorge-Luis Torres, Ignacio Novo-Veleiro, Laura Manzanedo, Lucía Alvela-Suárez, Ronald Macías, Francisco-Javier Laso, Miguel Marcos. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2018; 24(36): 4104-4118 doi: 10.3748/wjg.v24.i36.4104
41
Ruixian Huang, Xiaoyan Duan, Jangao Fan, Guangming Li, Baocan Wang. Role of Noncoding RNA in Development of Nonalcoholic Fatty Liver DiseaseBioMed Research International 2019; 2019: 1 doi: 10.1155/2019/8690592